Haichuan Hu, MD, PhD
Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA
Haichuan Hu graduated from Fudan University and received his oncology residency training in Fudan University Cancer Center. He is now a research fellow in Massachusetts General Hospital Cancer Center and focused on understanding the biological underpinnings of sensitivity and resistance to epidermal growth factor receptor (EGFR) inhibitor targeted therapies in lung cancers, in particular, how perturbation of speciﬁc signaling pathways impairs cell growth and induces cell death. He published his research works on high-impact journals including Journal of Clinical Oncology, Journal of Thoracic Oncology etc.